Company intelligence / Profile preview

CathVision

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

CathVision has developed the ECGenius System, a high-fidelity electrophysiology recording system with FDA clearance and CE Mark. The system provides advanced cardiac signal acquisition to improve diagnosis and treatment of complex heart rhythm disorders. Their CARDIALYTICS suite uses AI to deliver actionable insights during catheter ablation procedures. Clinical studies have demonstrated improved signal quality compared to conventional systems, supporting more informed decision-making in the EP lab. The company continues to expand commercial adoption while advancing R&D on new analytic modules.

Therapeutic areas: Cardiovascular
Modalities: DeviceAI-based analytics softwareNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Collaborations with leading hospitals such as Mt. Sinai Hospital (NYC)OLV Aalst Hospital (Belgium)NYU Langone HealthUniversity of Vermont Medical Center

Beyond the preview

Go deeper on CathVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CathVision.

Explore the full profile